Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cronos Group Inc. stock logo
CRON
Cronos Group
$3.21
+1.1%
$2.80
$2.28
$3.43
$1.19B0.91.34 million shs811,915 shs
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
$110.42
$110.42
$75.15
$115.00
$6.88B0.38180 shsN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$4.72
+0.7%
$4.54
$3.67
$23.20
$642.18M1.94.31 million shs1.20 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cronos Group Inc. stock logo
CRON
Cronos Group
+2.92%+16.54%+15.27%+15.69%+23.83%
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
0.00%0.00%0.00%0.00%0.00%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-2.09%+5.64%+4.93%-14.91%-50.76%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cronos Group Inc. stock logo
CRON
Cronos Group
$3.21
+1.1%
$2.80
$2.28
$3.43
$1.19B0.91.34 million shs811,915 shs
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
$110.42
$110.42
$75.15
$115.00
$6.88B0.38180 shsN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$4.72
+0.7%
$4.54
$3.67
$23.20
$642.18M1.94.31 million shs1.20 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cronos Group Inc. stock logo
CRON
Cronos Group
+2.92%+16.54%+15.27%+15.69%+23.83%
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
0.00%0.00%0.00%0.00%0.00%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-2.09%+5.64%+4.93%-14.91%-50.76%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cronos Group Inc. stock logo
CRON
Cronos Group
2.20
Hold$2.30-28.24% Downside
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
0.00
N/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
2.50
Moderate Buy$11.00133.30% Upside

Current Analyst Ratings Breakdown

Latest STDAF, CRON, and TLRY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/7/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
Reiterated RatingSell (E+)
7/31/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
UpgradeStrong-Buy
7/14/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
Lower Price TargetBuy$7.00 ➝ $5.00
5/29/2026
Cronos Group Inc. stock logo
CRON
Cronos Group
Reiterated RatingSell (D+)
5/13/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
DowngradeSell (D-)Sell (E+)
(Data available from 8/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cronos Group Inc. stock logo
CRON
Cronos Group
$146.59M8.11$0.01 per share245.67$3.01 per share1.06
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
$3.84B1.79$11.12 per share9.93$23.11 per share4.78
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$915.45M0.70N/AN/A$13.68 per share0.34
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cronos Group Inc. stock logo
CRON
Cronos Group
-$9.45M$0.2016.03N/AN/A39.08%4.85%4.62%N/A
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
$292.15MN/AN/AN/AN/AN/AN/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$121.40M-$1.08N/AN/AN/A-13.11%-7.76%-5.59%10/8/2026 (Estimated)

Latest STDAF, CRON, and TLRY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Cronos Group Inc. stock logo
CRON
Cronos Group
$0.01$0.09+$0.08$0.09$44.20 million$53.01 million
7/28/2026Q4 2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$0.0120-$0.43-$0.4180-$0.43$246.30 million$281.71 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cronos Group Inc. stock logo
CRON
Cronos Group
N/AN/AN/AN/AN/A
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
N/AN/AN/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cronos Group Inc. stock logo
CRON
Cronos Group
N/A
16.18
15.25
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
2.23
1.54
0.99
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
0.22
2.21
1.37

Institutional Ownership

CompanyInstitutional Ownership
Cronos Group Inc. stock logo
CRON
Cronos Group
8.71%
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
N/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
9.35%

Insider Ownership

CompanyInsider Ownership
Cronos Group Inc. stock logo
CRON
Cronos Group
7.80%
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
N/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
0.84%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cronos Group Inc. stock logo
CRON
Cronos Group
450370.73 million341.81 millionOptionable
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
12,50062.34 millionN/ANot Optionable
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
3,595136.20 million135.06 millionOptionable

Recent News About These Companies

Tilray Brands (NASDAQ:TLRY) Trading Down 3.3% - What's Next?
Tilray to cease brewing at Terrapin site in US
BrewDog Claims London’s Summer Park Season with ‘Park IPA’
Top Cannabis Stocks To Follow Today - August 7th

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cronos Group stock logo

Cronos Group NASDAQ:CRON

$3.20 +0.04 (+1.10%)
As of 11:54 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

STADA Arzneimittel Aktiengesellschaft stock logo

STADA Arzneimittel Aktiengesellschaft OTCMKTS:STDAF

$110.42 0.00 (0.00%)
As of 10/24/2022

STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.

Tilray Brands stock logo

Tilray Brands NASDAQ:TLRY

$4.72 +0.04 (+0.75%)
As of 11:54 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.